Barrow, Hanley, Mewhinney & Strauss’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226M | Sell |
|
|||||
|
2025
Q1 | $553M | Buy |
|
|||||
|
2024
Q4 | $289M | Sell |
|
|||||
|
2024
Q3 | $442M | Sell |
|
|||||
|
2024
Q2 | $668M | Sell |
|
|||||
|
2024
Q1 | $660M | Sell |
|
|||||
|
2023
Q4 | $645M | Sell |
|
|||||
|
2023
Q3 | $597M | Buy |
|
|||||
|
2023
Q2 | $550M | Sell |
|
|||||
|
2023
Q1 | $585M | Sell |
|
|||||
|
2022
Q4 | $745M | Sell |
|
|||||
|
2022
Q3 | $685M | Sell |
|
|||||
|
2022
Q2 | $779M | Sell |
|
|||||
|
2022
Q1 | $806M | Sell |
|
|||||
|
2021
Q4 | $812M | Sell |
|
|||||
|
2021
Q3 | $687M | Buy |
|
|||||
|
2021
Q2 | $692M | Buy |
|
|||||
|
2021
Q1 | $592M | Buy |
|
|||||
|
2020
Q4 | $486M | Sell |
|
|||||
|
2020
Q3 | $421M | Sell |
|
|||||
|
2020
Q2 | $423M | Sell |
|
|||||
|
2020
Q1 | $409M | Buy |
|
|||||
|
2019
Q4 | $517M | Sell |
|
|||||
|
2019
Q3 | $868M | Sell |
|
|||||
|
2019
Q2 | $1.08B | Buy |
|
|||||
|
2019
Q1 | $545M | Sell |
|
|||||
|
2018
Q4 | $537M | Sell |
|
|||||
|
2018
Q3 | $637M | Sell |
|
|||||
|
2018
Q2 | $581M | Buy |
|
|||||
|
2018
Q1 | $532M | Sell |
|
|||||
|
2017
Q4 | $557M | Sell |
|
|||||
|
2017
Q3 | $490M | Sell |
|
|||||
|
2017
Q2 | $1.25B | Sell |
|
|||||
|
2017
Q1 | $1.25B | Sell |
|
|||||
|
2016
Q4 | $1.16B | Sell |
|
|||||
|
2016
Q3 | $1.05B | Sell |
|
|||||
|
2016
Q2 | $1.13B | Buy |
|
|||||
|
2016
Q1 | $1.01B | Sell |
|
|||||
|
2015
Q4 | $1.03B | Sell |
|
|||||
|
2015
Q3 | $1.06B | Sell |
|
|||||
|
2015
Q2 | $1.26B | Sell |
|
|||||
|
2015
Q1 | $1.21B | Sell |
|
|||||
|
2014
Q4 | $1.03B | Sell |
|
|||||
|
2014
Q3 | $1.29B | Sell |
|
|||||
|
2014
Q2 | $1.27B | Sell |
|
|||||
|
2014
Q1 | $1.32B | Sell |
|
|||||
|
2013
Q4 | $1.61B | Buy |
|
|||||
|
2013
Q3 | $1.45B | Sell |
|
|||||
|
2013
Q2 | $1.43B | Buy |
|